BioPharma
Novartis-Argo $5.2 Licensing Deal for Heart Drugs
Argo Biopharmaceutical from China, which happens to be a clinical-stage biotechnology company that’s focused on developing next-generation siRNA therapeutics, has gone on to enter into...
BioPharma
Pharma Cold Chain Workforce Competency Frameworks
Building Excellence Through Structured Competency Development
The pharmaceutical cold chain industry demands highly skilled professionals who can manage complex temperature-controlled systems while ensuring regulatory compliance and...
BioPharma
Optimizing DMF Quality for Successful Health Authority Filings
A Drug Master File (DMF) is a confidential regulatory submission that provides comprehensive, precise, and accurate data about an Active Pharmaceutical Ingredient (API) or a...
BioPharma
LOTTE BIOLOGICS Enters Contract Manufacturing Collaboration
LOTTE BIOLOGICS, on September 1, 2025, announced that it has gone on to enter into a late-stage commercial contract manufacturing collaboration along with one of...
BioPharma
Er-Kim Announces Exclusive Agreement with CNX Therapeutics to Distribute...
Partnership will broaden portfolio distribution of oncology products to cancer patients in the specified regions
Er-Kim, an international pharmaceutical company specializing in the commercialization of novel...
BioPharma
$2 Billion Expansion By J&J in North Carolina Facility
Johnson & Johnson on August 21, 2025, went on to announce that it will be adding another 160,000 ft.² dedicated manufacturing facility in its Fujifilm...
BioPharma
Chinese Pharmaceutical Firms Turn to Local Reagent Suppliers
The Chinese pharmaceutical firms are increasingly looking out for the local reagent suppliers so as to cut the costs as well as delivery times. Growing...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.